Delving into the Latest Updates on Olygose SAS with Synapse

概览

关联

1

项与 Olygose SAS 相关的临床试验

Effect of the Alpha-galacto-oligasaccharides on Weight Loss in Overweight or Moderately Obeses Adults : A Randomized Controlled Double Blinded Trial Versus Placebo

Clinical intervention on overweight or moderately obeses adults. The objective of this trial is to demonstrate the superior eficacy of Alphagos to placebo on weight loss during a low-calorie diet of 12 weeks. The superiority is judged on body weight. Change in cardiometabolic risk factors through the intervention have been evaluated as secondary endpoints

开始日期2013-09-01

申办/合作机构

Olygose SAS

[+1]

100 项与 Olygose SAS 相关的临床结果

登录后查看更多信息

0 项与 Olygose SAS 相关的专利（医药）

登录后查看更多信息

100 项与 Olygose SAS 相关的药物交易

登录后查看更多信息

100 项与 Olygose SAS 相关的转化医学

登录后查看更多信息